Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo 11/7/2024 Earnings Results & Report

Terumo logo
$14.59 +0.33 (+2.31%)
As of 03:58 PM Eastern

Terumo reported earnings on November 7, 2024. The company reported EPS of $0.13, while revenue was $1.68 billion.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Report Date
Time
Before Market Opens

Terumo EPS Results

Actual EPS
$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 7 quarters

Terumo Revenue Results

Actual Revenue
$1.68 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.13 per share for the quarter. The report was announced on Thursday, November 7, 2024.

Terumo reported revenue of $1.68 billion for the quarter.

Terumo's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Terumo on the company's earnings history page.

Terumo Earnings Headlines

Contrasting Terumo (OTCMKTS:TRUMY) & Venus Concept (NASDAQ:VERO)
October 12 at 4:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31109738
Reviewing Integer (NYSE:ITGR) & Terumo (OTCMKTS:TRUMY)
October 11 at 2:14 PM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31108696
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
October 13 at 1:00 AM  |  Stansberry Research (Ad)
Reviewing Bausch + Lomb (NYSE:BLCO) & Terumo (OTCMKTS:TRUMY)
October 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31085069
Terumo ADR (TRUMY)
September 5, 2026  |  es.investing.comhttps://es.investing.com/equities/terumo-adr
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935290-terumo-corporation-trumy-q1-2027-earnings-call-prepared-remarks-transcript
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions. Its portfolio includes interventional devices and systems used in cardiovascular procedures, blood collection and processing equipment, transfusion products, infusion and injection devices, and other products designed to support patient care and clinical workflows. The company also provides technologies for diabetes management and other specialized medical applications.

Terumo serves healthcare providers and patients internationally through operations and distribution networks spanning Japan, the Americas, Europe, Asia and other markets. Its products are used across a range of medical specialties, including cardiovascular care, blood management, interventional procedures, infusion therapy and hospital operations.

View Terumo Profile
Earnings Tools